BeStock  
Stocks › Biotechnology › RXRX

Recursion Pharmaceuticals RXRX

US equityMarket cap rank #2603BiotechnologyAI medical concept stocks
$4.78 +$0.66 (+16.02%)
Pre-market · Oct 6, 4:10 am ET · After hours $4.76 -0.42%
Open$4.16
Prev close$4.12
Day range$4.06 – $4.94
Volume67.28M
Market cap$2.56B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±5.3%last 11 reports
Closed higher3 of 1127% of the time
Best reaction+6.8%
Worst reaction-16.6%

Stock move on the day after each report

-16.6%2023/Q4-0.5%2024/Q1+4.2%2024/Q2-0.6%2024/Q3-2.1%2024/Q4-16.6%2025/Q1-4.7%2025/Q2-0.8%2025/Q3+6.8%2025/Q4+1.8%2026/Q1-4.2%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026Pre Market±8.1%-4.23%Within range
2026/Q16 May 2026Pre Market±8.1%+1.78%Within range
2025/Q425 Feb 2026Pre Market±7.6%+6.80%Within range
2025/Q35 Nov 2025Pre Market±10.6%-0.80%Within range
2025/Q25 Aug 2025Pre Market±13.9%-4.66%Within range
2025/Q15 May 2025Pre Market±16.8%-16.58%Within range
2024/Q428 Feb 2025Pre Market±16.0%-2.09%Within range
2024/Q36 Nov 2024After Market±14.5%-0.57%Within range
2024/Q28 Aug 2024Pre Market±22.8%+4.24%Within range
2024/Q19 May 2024After Market±13.8%-0.46%Within range
2023/Q427 Feb 2024After Market–-16.62%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Discussion

No comments yet — be the first to weigh in on RXRX.

Leave a comment

Scroll to Top